2014年9月19日(星期五)上午
Friday Morning, Sept.19th, 2014
Lymphoma Forum for Young Investigators
Venue: 2C Meeting Room, 2nd Floor, Xiamen International Conference Center
Co-Chairs: Owen O’Connor Columbia University, USA
Francine Foss Yale University, USA
Pier Paolo Piccaluga University of Bologna, Italy
Moderators: Wei-Li Zhao 赵维莅 Shanghai Ruijin Hospital, China
Ye Guo 郭 晔 Fudan University Cancer Center, China
Young Competitors
08:30~08:40 Opening speech by chair
08:40~09:10 Clinical research of extranodal Natural Killer (NK)/T-cell lymphoma in Sun Yat-Sen University Cancer Center
Zhi-Ming Li 李志铭 Sun Yat-Sen University Cancer Center, China
09:10~09:40 CAR T-cell therapy for CD30+ lymphomas: ready to go
Ling-Yan Ping 平凌燕 Beijing Cancer Hospital, China
09:40~10:10 Signaling transduction pathway: Targeted therapy in malignant lymphoma
Li Wang 王 黎 Shanghai Ruijin Hospital, China
10:10~10:40 Is doxorubicin still the standard anthracycline in the management of non-Hodgkin lymphoma?
Kai Xue 薛 恺 Fudan University Cancer Center, China
10:40~11:10 Autologous stem cell transplantation as the first-line treatment for aggressive T cell lymphoma: a single center experience
De-Hui Zou 邹德慧 Institute of Hematology & Blood Disease Hospital, CAMS & PUMC, China
11:10~11:40 How to detect high risk CNS relapse DLBCL
Yan Qin 秦 燕 Cancer Hospital and Institute, CAMS & PUMC, China
11:40~12:00 Declaration of best presenters and closing speech by Chair